Herrero C, Muniesa A
Med Cutan Ibero Lat Am. 1980;8(4-6):139-45.
The treatment of Porphyria Cutaneous Tarda (PCT) has greatly improved by the introduction of low-dose chloroquine. The authors report the results in the treatment of 17 patients presenting PCT. The clinical and biological controls of these patients at the 6th and 12th months of treatment showed the disappearance of clinical signs and the normalization of liver function tests and porphyrin excretion between and 6th and the 12th months of treatment in all the cases.
